glp-1 and dpp4 together degrade the GLP1 incretion, which leads to suppression of the DPP-4 inhibitors in the treatment

[PubMed: 10694311] 14

The rate of having another stroke was similar between patients who did and did not receive either medication, at approximately 6%

It is FDA-approved for adults and pediatric patients aged 12 and older with obesity or overweight and at least one weight-related comorbidity.13 Liraglutide lowers blood sugar by enhancing insulin release and reducing appetite, with studies demonstrating a 15% reduction in caloric intake and an average weight loss of 18.5 lbs.10,14,15 While its mechanism of action is similar to semaglutide, liraglutide differs in dose, frequency, and formulation and should not be used interchangeably

Medications, if prescribed, are an additional cost

And in addition, Semaglutide blocks a hormone that causes your liver to release sugar (glucagon)

Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae